New therapeutic applications of ozenoxacin in superficial skin infections
In recent years, the incidence of community-acquired methicillin-resistant S. aureus skin infections (CA-MARSA) has increased in pediatric population without associated risk factors. Ozenoxacin 10mg/g is a topical quinolone that has shown high activity on strains of S. aureus, S. pyogenes and other...
Main Authors: | Gema García Ron, María Villa Arranz |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2021-08-01
|
Series: | Dermatology Reports |
Subjects: | |
Online Access: | https://www.pagepress.org/journals/index.php/dr/article/view/9289 |
Similar Items
-
The Use of Ozenoxacin in Pediatric Patients: Clinical Evidence, Efficacy and Safety
by: Giusy Davino, et al.
Published: (2020-11-01) -
New Antibiotics for the Treatment of Acute Bacterial Skin and Soft Tissue Infections in Pediatrics
by: Nicola Principi, et al.
Published: (2020-10-01) -
Features and associated factors of bacterial skin infections in hospitalized patients with pemphigus: a single-center retrospective study
by: Furong Li, et al.
Published: (2020-10-01) -
Antimicrobial stewardship in patients with acute bacterial skin and skin-structure infections: An international Delphi consensus
by: Alex Soriano, et al.
Published: (2020-09-01) -
Skin Infections Caused by Staphylococcus aureus
by: Pascal Del Giudice
Published: (2020-04-01)